Brooklyn ImmunoTherapeutics, LLC
2 clinical trials · Sponsor
◉ Watch Brooklyn ImmunoTherapeutics, LLC
| Record | Firm | Date |
|---|---|---|
| IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity (NCT02609386) | Brooklyn ImmunoTherapeutics, LLC | 2016-01-11 |
| A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer (NCT00210470) | Brooklyn ImmunoTherapeutics, LLC | 2005-07-01 |
Track Brooklyn ImmunoTherapeutics, LLC automatically
Every clearance here is in the API, with alerts when new ones post.